Characterization of the Proinflammatory Cytokine Profile during Acute SARS-CoV-2 Infection in People with Human Immunodeficiency Virus

Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in p...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Infectious Diseases Vol. 77; no. 6; pp. 301 - 310
Main Authors Anzurez, Alitzel, Runtuwene, Lucky, Dang, Thi Thu Thao, Nakayama-Hosoya, Kaori, Koga, Michiko, Yoshimura, Yukihiro, Sasaki, Hiroaki, Miyata, Nobuyuki, Miyazaki, Kazuhito, Takahashi, Yoshimasa, Suzuki, Tadaki, Yotsuyanagi, Hiroshi, Tachikawa, Natsuo, Matano, Tetsuro, Kawana-Tachikawa, Ai
Format Journal Article
LanguageEnglish
Published Japan National Institute of Infectious Diseases 29.11.2024
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in people with HIV (PWH) with effective combination antiretroviral therapy. There were no significant differences in any of the measured cytokines between severity levels of coronavirus disease 2019 (COVID-19) in PWH, while most were significantly higher in HIV-uninfected individuals with severe COVID-19, suggesting that excess cytokines release by hyperinflammatory responses do not occur in individuals with severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, particularly between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady-state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that they were in an enhanced inflammatory state. The absence of several inter-cytokine correlations was observed in in vitro lipopolysaccharide stimulus-driven cytokine production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially because of the underlying inflammatory state and/or impairment of innate immune cells.
AbstractList Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in people with HIV (PWH) with effective combination antiretroviral therapy. There were no significant differences in any of the measured cytokines between severity levels of coronavirus disease 2019 (COVID-19) in PWH, while most were significantly higher in HIV-uninfected individuals with severe COVID-19, suggesting that excess cytokines release by hyperinflammatory responses do not occur in individuals with severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, particularly between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady-state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that they were in an enhanced inflammatory state. The absence of several inter-cytokine correlations was observed in in vitro lipopolysaccharide stimulus-driven cytokine production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially because of the underlying inflammatory state and/or impairment of innate immune cells.Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in people with HIV (PWH) with effective combination antiretroviral therapy. There were no significant differences in any of the measured cytokines between severity levels of coronavirus disease 2019 (COVID-19) in PWH, while most were significantly higher in HIV-uninfected individuals with severe COVID-19, suggesting that excess cytokines release by hyperinflammatory responses do not occur in individuals with severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, particularly between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady-state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that they were in an enhanced inflammatory state. The absence of several inter-cytokine correlations was observed in in vitro lipopolysaccharide stimulus-driven cytokine production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially because of the underlying inflammatory state and/or impairment of innate immune cells.
Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in people with HIV (PWH) with effective combination antiretroviral therapy. There were no significant differences in any of the measured cytokines between severity levels of coronavirus disease 2019 (COVID-19) in PWH, while most were significantly higher in HIV-uninfected individuals with severe COVID-19, suggesting that excess cytokines release by hyperinflammatory responses do not occur in individuals with severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, particularly between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady-state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that they were in an enhanced inflammatory state. The absence of several inter-cytokine correlations was observed in in vitro lipopolysaccharide stimulus-driven cytokine production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially because of the underlying inflammatory state and/or impairment of innate immune cells.
ArticleNumber JJID.2024.184
Author Koga, Michiko
Suzuki, Tadaki
Yotsuyanagi, Hiroshi
Nakayama-Hosoya, Kaori
Sasaki, Hiroaki
Miyata, Nobuyuki
Miyazaki, Kazuhito
Takahashi, Yoshimasa
Runtuwene, Lucky
Matano, Tetsuro
Kawana-Tachikawa, Ai
Dang, Thi Thu Thao
Tachikawa, Natsuo
Anzurez, Alitzel
Yoshimura, Yukihiro
Author_xml – sequence: 1
  fullname: Anzurez, Alitzel
  organization: AIDS Research Center, National Institute of Infectious Diseases, Japan
– sequence: 2
  fullname: Runtuwene, Lucky
  organization: AIDS Research Center, National Institute of Infectious Diseases, Japan
– sequence: 3
  fullname: Dang, Thi Thu Thao
  organization: AIDS Research Center, National Institute of Infectious Diseases, Japan
– sequence: 4
  fullname: Nakayama-Hosoya, Kaori
  organization: AIDS Research Center, National Institute of Infectious Diseases, Japan
– sequence: 5
  fullname: Koga, Michiko
  organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan
– sequence: 6
  fullname: Yoshimura, Yukihiro
  organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan
– sequence: 7
  fullname: Sasaki, Hiroaki
  organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan
– sequence: 8
  fullname: Miyata, Nobuyuki
  organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan
– sequence: 9
  fullname: Miyazaki, Kazuhito
  organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan
– sequence: 10
  fullname: Takahashi, Yoshimasa
  organization: Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Japan
– sequence: 11
  fullname: Suzuki, Tadaki
  organization: Department of Pathology, National Institute of Infectious Diseases, Japan
– sequence: 12
  fullname: Yotsuyanagi, Hiroshi
  organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan
– sequence: 13
  fullname: Tachikawa, Natsuo
  organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan
– sequence: 14
  fullname: Matano, Tetsuro
  organization: AIDS Research Center, National Institute of Infectious Diseases, Japan
– sequence: 15
  fullname: Kawana-Tachikawa, Ai
  organization: AIDS Research Center, National Institute of Infectious Diseases, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38945856$$D View this record in MEDLINE/PubMed
BookMark eNqFkstu3CAUhlGVqrm0T1CpQuqmG09tgzFejtw2cRSpURNlizA-ZJjYMAWsyn2APHc9l47UbLoBJL7_HODjHJ1YZwGh91m6KDknnyf3BHZxfd18WeRpThcZp6_QWcY5TXJO2Mm8JpQmjKT0FJ2HsE7TvCiy9A06JbyiBS_YGXquV9JLFcGb3zIaZ7HTOK4A33pnrO7lMMjo_ITrKbonY3cb2vSAu9Eb-4iXaoyA75Y_7pLaPSQ5bqwGtatkLL4Ft5nZXyau8NU4SIubYRit60AbZcCqCT8YP4a36LWWfYB3h_kC3X_7el9fJTffL5t6eZMomhc06QgUUgKkoHXBWKHTllaMAXTZfGPKWwKy5BnQkiqZy6ojFc9UQbpWA7Q5uUCf9mU33v0cIUQxmKCg76UFNwZB0pJmhJSEzOjHF-jajd7OhxMkY6wqcsKqmfpwoMZ2gE5svBmkn8TfB54BsgeUdyF40EckS8VWo9hpFFuNYqtRzBrnVPUipUzc6Ylemv4_2WafXYcoH-HYT_poVA-HTFkKth3-yR4ZNX8KAZb8AbXLwK0
CitedBy_id crossref_primary_10_3390_v17010091
Cites_doi 10.1089/aid.2011.0073
10.1371/journal.ppat.1009674
10.4049/jimmunol.168.7.3660
10.1186/s12981-023-00519-x
10.1111/hiv.13515
10.1093/cid/ciab1008
10.1097/QAD.0000000000003597
10.1097/QAI.0000000000002578
10.1038/s41591-020-1051-9
10.1016/j.coi.2012.05.004
10.1016/j.cytogfr.2020.06.001
10.1038/s41467-021-26137-7
10.3389/fimmu.2022.974767
10.1182/blood-2002-07-2103
10.1189/jlb.0410231
10.1038/nature05115
10.7189/jogh.12.05036
10.1128/JVI.01545-07
10.1093/infdis/jiac343
10.1097/QAD.0000000000003276
10.1182/blood.V96.9.3094.h8003094_3094_3101
10.3389/fimmu.2022.832394
10.3390/v12070711
10.3389/fimmu.2019.02677
10.1097/QAD.0000000000000174
10.1101/2023.07.23.23293053
10.1371/journal.pone.0022982
10.7554/eLife.78374
10.1128/JVI.01153-09
10.18637/jss.v025.i01
10.1097/QAD.0b013e328351f756
10.1186/s12933-023-02097-8
10.1016/S2352-3018(21)00239-3
10.1002/jia2.26104
10.1186/s12879-023-08817-5
ContentType Journal Article
Copyright 2024 Authors
Copyright Japan Science and Technology Agency 2024
Copyright_xml – notice: 2024 Authors
– notice: Copyright Japan Science and Technology Agency 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7TK
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
DOI 10.7883/yoken.JJID.2024.184
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1884-2836
EndPage 310
ExternalDocumentID 38945856
10_7883_yoken_JJID_2024_184
article_yoken_77_6_77_JJID_2024_184_article_char_en
Genre Journal Article
GroupedDBID ---
.55
29J
2WC
53G
5GY
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
JSF
JSH
KQ8
OK1
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
AAYXX
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7TK
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
ID FETCH-LOGICAL-c4254-d3e5aaee0eff5665f0b4966eed183648b3ea781e474ca2a9d3981c53dbfeeb23
ISSN 1344-6304
1884-2836
IngestDate Fri Jul 11 09:33:02 EDT 2025
Mon Jun 30 11:57:58 EDT 2025
Thu Jan 02 22:40:01 EST 2025
Thu Apr 24 22:58:24 EDT 2025
Tue Jul 01 03:55:25 EDT 2025
Thu Dec 05 17:45:04 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords SARS-CoV-2
proinflammatory cytokines
innate responses
HIV
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4254-d3e5aaee0eff5665f0b4966eed183648b3ea781e474ca2a9d3981c53dbfeeb23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/yoken/77/6/77_JJID.2024.184/_article/-char/en
PMID 38945856
PQID 3166952369
PQPubID 2048383
PageCount 10
ParticipantIDs proquest_miscellaneous_3074133733
proquest_journals_3166952369
pubmed_primary_38945856
crossref_primary_10_7883_yoken_JJID_2024_184
crossref_citationtrail_10_7883_yoken_JJID_2024_184
jstage_primary_article_yoken_77_6_77_JJID_2024_184_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024/11/29
PublicationDateYYYYMMDD 2024-11-29
PublicationDate_xml – month: 11
  year: 2024
  text: 2024/11/29
  day: 29
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Japanese Journal of Infectious Diseases
PublicationTitleAlternate Jpn J Infect Dis
PublicationYear 2024
Publisher National Institute of Infectious Diseases
Japan Science and Technology Agency
Publisher_xml – sequence: 0
  name: National Institute of Infectious Diseases
– name: Japan Science and Technology Agency
References 12. Lee MY, Upadhyay AA, Walum H, et al. Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infection. PLoS Pathog. 2021;17:e1009674.
28. COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023;621:E7-E26.
1. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol. 2012;24:501-506.
23. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at <https://www.R-project.org/>, 2021. Accessed July 23, 2024.
32. Hearps AC, Maisa A, Cheng WJ, et al. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012;26:843-853.
6. Favara G, Barchitta M, Maugeri A, et al. HIV infection does not affect the risk of death of COVID-19 patients: a systematic review and meta-analysis of epidemiological studies. J Glob Health. 2022;12:05036.
39. Noel N, Boufassa F, Lécuroux C, et al. Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients. AIDS. 2014;28:467-476.
34. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol. 2002;168:3660-3666.
40. Semulimi AW, Batte C, Bayiyana A, et al. Serum E-selectin and endothelial cell-specific molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study. AIDS Res Ther. 2023;20:26.
13. Hove-Skovsgaard M, Moller DL, Hald A, et al. Improved induced innate immune response after cART initiation in people with HIV. Front Immunol. 2022;13:974767.
27. Hsu RJ, Yu WC, Peng GR, et al. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Front Immunol. 2022;13:832394.
29. Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585.
8. Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636-1643.
19. Khan K, Lustig G, Bernstein M, et al. Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26.CoV2.S vaccination in people living with human immunodeficiency virus (HIV). Clin Infect Dis. 2022;75:e857-e864.
30. Tilton JC, Manion MM, Luskin MR, et al. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol. 2008;82:3997-4006.
26. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75.
2. Yang X, Sun J, Patel RC, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021;8:e690-e700.
33. Akiyama H, Gummuluru S. HIV-1 persistence and chronic induction of innate immune responses in macrophages. Viruses. 2020;12:711.
7. Moller IK, Gisslen M, Wagner P, et al. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study. HIV Med. 2023;24:1045-1055.
11. Coindre S, Tchitchek N, Alaoui L, et al. Mass cytometry analysis reveals complex cell-state modifications of blood myeloid cells during HIV infection. Front Immunol. 2019;10:2677.
3. Kassanjee R, Davies MA, Ngwenya O, et al. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa. J Int AIDS Soc. 2023;26:e26104.
10. Centlivre M, Legrand N, Steingrover R, et al. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J Leukoc Biol. 2011;89:785-795.
36. Nakayama K, Nakamura H, Koga M, et al. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Res Hum Retroviruses. 2012;28:702-714.
14. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711-2720.
18. Hwa SH, Snyman J, Bernstein M, et al. Association between human immunodeficiency virus viremia and compromised neutralization of severe acute respiratory syndrome coronavirus 2 beta variant. J Infect Dis. 2023;227:211-220.
37. Valencia I, Lumpuy-Castillo J, Magalhaes G, et al. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. Cardiovasc Diabetol. 2024;23:75.
22. Wei T, Simko V. R package 'corrplot': visualization of a correlation matrix (Version 0.92). Available at <https://github.com/taiyun/corrplot>, 2021. Accessed July 23, 2024.
25. Sebastien Le JJ, Francois Husson. FactoMineR: an R package for multivariate analysis. J Statistical Software. 2008;25:1-18.
31. Mangino G, Percario ZA, Fiorucci G, et al. HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS One. 2011;6:e22982.
4. Wit FWNM, Reiss P, Rijnders B, et al. COVID-19 in people with HIV in the Netherlands. AIDS. 2023;37:1671-1681.
16. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350-354.
21. Donadeu L, Tiraboschi JM, Scevola S, et al. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV. AIDS. 2022;36:1373-1382.
24. Kassambara A, Mundt f. Factoextra: extract and visualize the results of multivariate data analyses. R package version 1.0.7, Available at <https://CRAN.R-project.org/package=factoextra>, 2020. Accessed July 23, 2024.
20. Alrubayyi A, Gea-Mallorqui E, Touizer E, et al. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV. Nat Commun. 2021;12:5839.
17. Nkosi T, Chasara C, Papadopoulos AO, et al. Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition. Elife. 2022;11:e78374.
38. Guha D, Misra V, Yin J, et al. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023;37:2137-2147.
5. Patel VV, Felsen UR, Fisher M, et al. Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2021;86:224-230.
15. Migueles SA, Weeks KA, Nou E, et al. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol. 2009;83:11876-11889.
35. Shankar P, Russo M, Harnisch B, et al. Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection. Blood. 2000;96:3094-3101.
9. Nakayama R, Bunya N, Tagami T, et al. Associated organs and system with COVID-19 death with information of organ support: a multicenter observational study. BMC Infect Dis. 2023;23:814.
22
23
24
25
26
27
28
29
30
31
10
32
11
33
12
34
13
35
14
36
15
37
16
38
17
39
18
19
1
2
3
4
5
6
7
8
9
40
20
21
References_xml – reference: 37. Valencia I, Lumpuy-Castillo J, Magalhaes G, et al. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. Cardiovasc Diabetol. 2024;23:75.
– reference: 19. Khan K, Lustig G, Bernstein M, et al. Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26.CoV2.S vaccination in people living with human immunodeficiency virus (HIV). Clin Infect Dis. 2022;75:e857-e864.
– reference: 25. Sebastien Le JJ, Francois Husson. FactoMineR: an R package for multivariate analysis. J Statistical Software. 2008;25:1-18.
– reference: 24. Kassambara A, Mundt f. Factoextra: extract and visualize the results of multivariate data analyses. R package version 1.0.7, Available at <https://CRAN.R-project.org/package=factoextra>, 2020. Accessed July 23, 2024.
– reference: 29. Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585.
– reference: 12. Lee MY, Upadhyay AA, Walum H, et al. Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infection. PLoS Pathog. 2021;17:e1009674.
– reference: 26. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75.
– reference: 5. Patel VV, Felsen UR, Fisher M, et al. Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2021;86:224-230.
– reference: 20. Alrubayyi A, Gea-Mallorqui E, Touizer E, et al. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV. Nat Commun. 2021;12:5839.
– reference: 28. COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023;621:E7-E26.
– reference: 4. Wit FWNM, Reiss P, Rijnders B, et al. COVID-19 in people with HIV in the Netherlands. AIDS. 2023;37:1671-1681.
– reference: 36. Nakayama K, Nakamura H, Koga M, et al. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Res Hum Retroviruses. 2012;28:702-714.
– reference: 18. Hwa SH, Snyman J, Bernstein M, et al. Association between human immunodeficiency virus viremia and compromised neutralization of severe acute respiratory syndrome coronavirus 2 beta variant. J Infect Dis. 2023;227:211-220.
– reference: 40. Semulimi AW, Batte C, Bayiyana A, et al. Serum E-selectin and endothelial cell-specific molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study. AIDS Res Ther. 2023;20:26.
– reference: 11. Coindre S, Tchitchek N, Alaoui L, et al. Mass cytometry analysis reveals complex cell-state modifications of blood myeloid cells during HIV infection. Front Immunol. 2019;10:2677.
– reference: 23. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at <https://www.R-project.org/>, 2021. Accessed July 23, 2024.
– reference: 27. Hsu RJ, Yu WC, Peng GR, et al. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Front Immunol. 2022;13:832394.
– reference: 15. Migueles SA, Weeks KA, Nou E, et al. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol. 2009;83:11876-11889.
– reference: 35. Shankar P, Russo M, Harnisch B, et al. Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection. Blood. 2000;96:3094-3101.
– reference: 30. Tilton JC, Manion MM, Luskin MR, et al. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol. 2008;82:3997-4006.
– reference: 17. Nkosi T, Chasara C, Papadopoulos AO, et al. Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition. Elife. 2022;11:e78374.
– reference: 33. Akiyama H, Gummuluru S. HIV-1 persistence and chronic induction of innate immune responses in macrophages. Viruses. 2020;12:711.
– reference: 22. Wei T, Simko V. R package 'corrplot': visualization of a correlation matrix (Version 0.92). Available at <https://github.com/taiyun/corrplot>, 2021. Accessed July 23, 2024.
– reference: 16. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350-354.
– reference: 39. Noel N, Boufassa F, Lécuroux C, et al. Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients. AIDS. 2014;28:467-476.
– reference: 6. Favara G, Barchitta M, Maugeri A, et al. HIV infection does not affect the risk of death of COVID-19 patients: a systematic review and meta-analysis of epidemiological studies. J Glob Health. 2022;12:05036.
– reference: 7. Moller IK, Gisslen M, Wagner P, et al. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study. HIV Med. 2023;24:1045-1055.
– reference: 9. Nakayama R, Bunya N, Tagami T, et al. Associated organs and system with COVID-19 death with information of organ support: a multicenter observational study. BMC Infect Dis. 2023;23:814.
– reference: 10. Centlivre M, Legrand N, Steingrover R, et al. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J Leukoc Biol. 2011;89:785-795.
– reference: 34. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol. 2002;168:3660-3666.
– reference: 21. Donadeu L, Tiraboschi JM, Scevola S, et al. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV. AIDS. 2022;36:1373-1382.
– reference: 31. Mangino G, Percario ZA, Fiorucci G, et al. HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS One. 2011;6:e22982.
– reference: 8. Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636-1643.
– reference: 38. Guha D, Misra V, Yin J, et al. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023;37:2137-2147.
– reference: 13. Hove-Skovsgaard M, Moller DL, Hald A, et al. Improved induced innate immune response after cART initiation in people with HIV. Front Immunol. 2022;13:974767.
– reference: 2. Yang X, Sun J, Patel RC, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021;8:e690-e700.
– reference: 3. Kassanjee R, Davies MA, Ngwenya O, et al. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa. J Int AIDS Soc. 2023;26:e26104.
– reference: 14. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711-2720.
– reference: 1. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol. 2012;24:501-506.
– reference: 32. Hearps AC, Maisa A, Cheng WJ, et al. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012;26:843-853.
– ident: 36
  doi: 10.1089/aid.2011.0073
– ident: 12
  doi: 10.1371/journal.ppat.1009674
– ident: 34
  doi: 10.4049/jimmunol.168.7.3660
– ident: 40
  doi: 10.1186/s12981-023-00519-x
– ident: 7
  doi: 10.1111/hiv.13515
– ident: 19
  doi: 10.1093/cid/ciab1008
– ident: 4
  doi: 10.1097/QAD.0000000000003597
– ident: 5
  doi: 10.1097/QAI.0000000000002578
– ident: 8
  doi: 10.1038/s41591-020-1051-9
– ident: 1
  doi: 10.1016/j.coi.2012.05.004
– ident: 26
  doi: 10.1016/j.cytogfr.2020.06.001
– ident: 28
– ident: 20
  doi: 10.1038/s41467-021-26137-7
– ident: 24
– ident: 13
  doi: 10.3389/fimmu.2022.974767
– ident: 14
  doi: 10.1182/blood-2002-07-2103
– ident: 10
  doi: 10.1189/jlb.0410231
– ident: 16
  doi: 10.1038/nature05115
– ident: 22
– ident: 6
  doi: 10.7189/jogh.12.05036
– ident: 30
  doi: 10.1128/JVI.01545-07
– ident: 18
  doi: 10.1093/infdis/jiac343
– ident: 21
  doi: 10.1097/QAD.0000000000003276
– ident: 35
  doi: 10.1182/blood.V96.9.3094.h8003094_3094_3101
– ident: 27
  doi: 10.3389/fimmu.2022.832394
– ident: 33
  doi: 10.3390/v12070711
– ident: 11
  doi: 10.3389/fimmu.2019.02677
– ident: 39
  doi: 10.1097/QAD.0000000000000174
– ident: 38
  doi: 10.1101/2023.07.23.23293053
– ident: 31
  doi: 10.1371/journal.pone.0022982
– ident: 17
  doi: 10.7554/eLife.78374
– ident: 15
  doi: 10.1128/JVI.01153-09
– ident: 29
– ident: 25
  doi: 10.18637/jss.v025.i01
– ident: 32
  doi: 10.1097/QAD.0b013e328351f756
– ident: 37
  doi: 10.1186/s12933-023-02097-8
– ident: 2
  doi: 10.1016/S2352-3018(21)00239-3
– ident: 3
  doi: 10.1002/jia2.26104
– ident: 9
  doi: 10.1186/s12879-023-08817-5
– ident: 23
SSID ssj0025510
Score 2.3682084
Snippet Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 301
SubjectTerms Adult
Aged
Antiretroviral agents
Antiretroviral therapy
Chronic infection
Coronaviruses
COVID-19
COVID-19 - blood
COVID-19 - immunology
Cytokines
Cytokines - blood
Female
HIV
HIV Infections - blood
HIV Infections - complications
HIV Infections - immunology
Human immunodeficiency virus
Humans
Immune response
Immune system
Infections
Inflammation
Inflammation - blood
innate responses
Intercellular adhesion molecule 1
IP-10 protein
Lipopolysaccharides
Male
Middle Aged
Plasma levels
proinflammatory cytokines
Respiratory diseases
SARS-CoV-2
SARS-CoV-2 - immunology
Severe acute respiratory syndrome coronavirus 2
Tumor necrosis factor-α
Viral diseases
α-Interferon
Title Characterization of the Proinflammatory Cytokine Profile during Acute SARS-CoV-2 Infection in People with Human Immunodeficiency Virus
URI https://www.jstage.jst.go.jp/article/yoken/77/6/77_JJID.2024.184/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/38945856
https://www.proquest.com/docview/3166952369
https://www.proquest.com/docview/3074133733
Volume 77
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Infectious Diseases, 2024/11/29, Vol.77(6), pp.301-310
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKQIgXxH8KAxmJt5HSxo7jPpayqau2UW3Z1LfISZytlCWobYTaD8AH45NxthOnrcYEPDSqUsex-vv5fHe-OyP0PkkYZ1GaOjH1hENj7jlRLNoOKMMurC6Sd3TI__EJG5zT4dgbNxq_1qKWikXUilc35pX8D6pwD3BVWbL_gKztFG7Ad8AXroAwXP8K476ttryymp9SJEezHLoHrK_NHnp_ucinSp0cmRO6q-TEXqyiBM56p2dOP79wXJAWJjRLhz-OdHC58dQaX_-hSibJE6mqTuiUzYvJrHQcVPotrL3qTMvNihSm02JebQdZPb6XrYqZ8WH3wB5YSRvvcVrAYvhDGn_rURFPres_uJrsBVcFfESuSHtp_dliKpbiWjiDfJ4vy1S3fDZZd2y4VGX4ubX41AO2Ek7tItSbDXs9nZi6JrcJpQ4j5iTjljT3OKcOaE9sXdiXZ8ZMasm9vYb4nKtaFst8KrPWcHj4uaUG1-pwWi-ZVZjAyZfw4PzoKAz2x8EddNcFU0UnnI9tmBFYbKYiRjVAU_lKveTjDa_Y0I7ufQUD4VL-2fbROlDwCD0sjRfcM0x8jBoye4LuH5fhGU_Rz21C4jzFQEi8RUhcERKXhMSGkFgTEteExJaQeJJhQ0isCIk1IfE2IbEm5DMUHOwH_YFTHvQBEsL1qJMQ6QkhZVumKZgXXtqOKJjhoL7BgsMoj4gUPu9I6tNYuKKbkC7vxB5JolTKyCXP0U6WZ_IlwkkaccGI9NWOPmMiYj6oY4Jzxn3iyaSJ3Or_DeOyCL46i-VbCMawAiXUoIQKlFCBEgIoTfTBPvTd1IC5vfknA5xtXAqIsrHvh0xdNh6ybVSyJci2JtqtQA_LGTsPSYexrucS1m2id_ZnWA_UJh_MbpjIIVE2AiE-IU30wpDFjgOME-pxj726vfPX6EE9H3fRzmJWyDegei-it5rbvwEAF-Ne
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+the+Proinflammatory+Cytokine+Profile+during+Acute+SARS-CoV-2+Infection+in+People+with+Human+Immunodeficiency+Virus&rft.jtitle=Japanese+journal+of+infectious+diseases&rft.au=Anzurez%2C+Alitzel&rft.au=Runtuwene%2C+Lucky&rft.au=Thi+Thu+Thao+Dang&rft.au=Nakayama-Hosoya%2C+Kaori&rft.date=2024-11-29&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=77&rft.issue=6&rft_id=info:doi/10.7883%2Fyoken.JJID.2024.184&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon